Our study is limited by a relatively small sample size, especially those with NT-proBNP level ≥400 pg/dL due to our exclusion of heart failure, in our cohort of women with signs and symptoms of ischemia, preserved LVEF and no obstructive CAD. This evidence concerns the gene NPPB and coronary artery disorder.